Myron Z. Holubiak, Director at BioScrip, Inc. (BIOS), sold 6,800 shares at $8.50 ($58K) on 2012-08-31, disclosed to the SEC on 2012-09-05.
Scheduled sale ($58k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 2,800 | $24K | 41.1% |
| 2 | $8.51 | 3,900 | $33K | 57.4% |
| 3 | $8.50 | 100 | $850 | 1.5% |
| Total | $8.51 avg | 6,800 | $58K | 100% |
| Filing → |
| CTXR | BUY | 2018-08-15 | $2.0M | — | Filing → |
| CTXR | BUY | 2018-03-29 | $9K | — | Filing → |
| BIOS | SELL | 2014-06-18 | $40K | — | Filing → |